Radiopharmeaceuticals

Radiopharmaceuticals are drugs that contain radioactive materials, known as radioisotopes. These drugs may be administered by multiple routes and travel to the body to treat cancer or to reduce symptoms. Radiopharmaceuticals release radiation (alpha and beta particles) that target the affected areas.
 
Everyone responds to radiopharmaceuticals differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.
 
Below is a list of common radiopharmaceuticals used to treat prostate cancer. Click on each drug name for further information including:
 
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Radium 223 Dichloride (Xofigo)
 




 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive